Prikaz osnovnih podataka o dokumentu

dc.creatorStojanović, Ivana D.
dc.creatorStošić-Grujičić, Stanislava
dc.date.accessioned2017-11-23T11:15:04Z
dc.date.available2900-01-01
dc.date.issued2006sr
dc.identifier.issn1567-5769sr
dc.identifier.otherRad_konverzija_3626sr
dc.identifier.urihttps://radar.ibiss.bg.ac.rs/handle/123456789/1631
dc.description.abstractMacrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine that plays an important role in the pathogenesis of numerous inflammatory and autoimmune disorders. As such, it is an attractive therapeutic target for the treatment of these disorders. Several groups of possible MIF inhibitors have so far been identified, including anti-MIF antibodies, small chemical compounds and plant-derived inhibitors. This review presents current understanding of the effects of MIF neutralization in a number of experimental animal models of inflammatory and autoimmune diseases and discusses the potential problems in translating this kind of therapy into human subjects. (c) 2006 Elsevier B.V. All rights reserved.en
dc.description.sponsorshipnullsr
dc.language.isoEnglishsr
dc.rightsrestrictedAccess
dc.sourceInternational Immunopharmacologysr
dc.titleNeutralization of macrophage migration inhibitory factor - novel approach for the treatment of immunoinflammatory disordersen
dc.typereview
dc.rights.licenseARR
dcterms.abstractСтошић-Грујичић, Станислава Д.; Цветковић, Ивана Д.;
dc.rights.holder© 2006 Elsevier B.V.
dc.citation.issue10sr
dc.citation.volume6sr
dc.identifier.doi10.1016/j.intimp.2006.06.009
dc.identifier.scopus2-s2.0-33747083848
dc.identifier.wos000240374300001
dc.citation.spage1527
dc.citation.epage1534sr
dc.type.versionpublishedVersionen
dc.citation.rankM23
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_ibiss_1631


Dokumenti

Thumbnail

Ovaj dokument se pojavljuje u sledećim kolekcijama

Prikaz osnovnih podataka o dokumentu